BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28496688)

  • 1. Atrial Fibrillation in the Wolff-Parkinson-White Syndrome.
    Centurion OA
    J Atr Fibrillation; 2011; 4(1):287. PubMed ID: 28496688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
    Centurión OA; Shimizu A; Isomoto S; Konoe A
    Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
    Hamada T; Hiraki T; Ikeda H; Kubara I; Yoshida T; Ohga M; Imaizumi T
    J Cardiovasc Electrophysiol; 2002 Mar; 13(3):223-9. PubMed ID: 11942586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome.
    Cagli KE; Topaloglu S; Aras D; Sen N; Akpinar I; Durak A; Kisacik HL
    J Interv Card Electrophysiol; 2009 Dec; 26(3):217-24. PubMed ID: 19844784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for atrioventricular tachycardia degenerating to atrial flutter/fibrillation in the young with Wolff-Parkinson-White.
    Harahsheh A; Du W; Singh H; Karpawich PP
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1307-12. PubMed ID: 18811812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different electrophysiological characteristics in children with Wolff-Parkinson-White syndrome between those with and without atrial fibrillation.
    Lee PC; Hwang B; Tai CT; Chiang CE; Yu WC; Chen SA
    Pacing Clin Electrophysiol; 2004 Feb; 27(2):235-9. PubMed ID: 14764177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early repolarization in the inferior leads after accessory pathway ablation is highly correlated with atrial fibrillation in Wolff-Parkinson-White syndrome.
    Chen M; Wang Q; Sun J; Zhang PP; Li W; Mo BF; Li YG
    J Cardiol; 2020 Mar; 75(3):323-329. PubMed ID: 31445855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance and Risk of Atrial Fibrillation of Wolff-Parkinson-White Syndrome in Patients With Hypertrophic Cardiomyopathy.
    Song C; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    Am J Cardiol; 2018 Nov; 122(9):1546-1550. PubMed ID: 30201118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial electrophysiologic abnormalities in patients with Wolff-Parkinson-White syndrome but without paroxysmal atrial fibrillation.
    Sakabe K; Fukuda N; Nada T; Shinohara H; Tamura Y; Wakatsuki T; Nishikado A; Oki T
    Clin Cardiol; 2004 Jul; 27(7):396-400. PubMed ID: 15298039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrence of atrial fibrillation after successful radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome].
    Mujović N; Grujić M; Mrdja S; Kocijancić A; Vujisić-Tesić B; Petrović M; Potpara T; Mujović N
    Srp Arh Celok Lek; 2010; 138(3-4):170-6. PubMed ID: 20499496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: role of pulmonary veins.
    Derejko P; Szumowski LJ; Sanders P; Krupa W; Bodalski R; Orczykowski M; Urbanek P; Zakrzewska J; Lim HS; Lau DH; Kuśnierz J; Walczak F
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):280-6. PubMed ID: 22035173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde multiple and multifiber accessory pathway conduction in the Wolff-Parkinson-White syndrome: potential precipitating factor of atrial fibrillation.
    Iesaka Y; Yamane T; Takahashi A; Goya M; Kojima S; Soejima Y; Okamoto Y; Fujiwara H; Aonuma K; Nogami A; Hiroe M; Marumo F; Hiraoka M
    J Cardiovasc Electrophysiol; 1998 Feb; 9(2):141-51. PubMed ID: 9511888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and atrial vulnerability in the Wolff-Parkinson-White syndrome.
    Asano Y; Kaneko K; Matsumoto K; Saito J; Yamamoto T; Dohi Y
    Jpn Circ J; 1991 Mar; 55(3):287-96. PubMed ID: 2030555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genesis of auricular fibrillation in the Wolff-Parkinson-White syndrome].
    Gressard A; Atallah G; Chatelain MT; Touboul P
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1277-82. PubMed ID: 6797365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the accessory pathway radiofrequency catheter ablation in the secondary prevention of the malignant tachyarrhythmias in patients with Wolff-Parkinson-White syndrome].
    Mujović N; Grujić M; Mrda S; Kocijancić A; Potpara T; Polovina M; Mujović N
    Vojnosanit Pregl; 2010 Jan; 67(1):48-54. PubMed ID: 20225635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W; Kuck KH
    Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
    Kose S; Amasyali B; Aytemir K; Can I; Kilic A; Kursaklioglu H; Iyisoy A; Isik E
    Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WPW and preexcitation syndromes.
    Sethi KK; Dhall A; Chadha DS; Garg S; Malani SK; Mathew OP
    J Assoc Physicians India; 2007 Apr; 55 Suppl():10-5. PubMed ID: 18368860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation.
    Kawabata M; Goya M; Takagi T; Yamashita S; Iwai S; Suzuki M; Takamiya T; Nakamura T; Hayashi T; Yagishita A; Sasaki T; Takahashi Y; Ono Y; Hachiya H; Yamauchi Y; Otomo K; Nitta J; Okishige K; Nishizaki M; Iesaka Y; Isobe M; Hirao K
    J Cardiol; 2016 Dec; 68(6):485-491. PubMed ID: 26917195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.